No Data
No Data
Express News | Pharmather Holdings Ltd - Generic Drug User Fee Amendments of 2022 Goal Date of October 29, 2024
Express News | Pharmather Holdings Ltd - Receipt of Amendment Acknowledgment Letter for Its Priority Original Abbreviated New Drug Application for Ketamine
Express News | Pharmather Holdings Ltd - Receipt of a Complete Response Letter ("Crl") for Its Priority Original Abbreviated New Drug Application for Ketamine
Express News | Pharmather Holdings Ltd: Has Completed Necessary Tests and Responses to Address Fda's Comments
PharmaTher Updated on Its Priority Original Abbreviated New Drug Application for Ketamine
PharmaTher Holdings Ltd. (PHRM.CN), a specialty pharmaceutical company, on Tuesday provided an update on its Priority Original Abbreviated New Drug Application (ANDA) for Ketamine that was accepted by
PharmaTher Provides Update on Its Priority Original Abbreviated New Drug Application For Ketamine
PharmaTher Holdings Ltd. (PHRM.CSE), a commercial-focused specialty pharmaceutical company, on Monday provided an update on its Priority Original Abbreviated New Drug Application (ANDA) for Ketamine t